Application of Compound Naproxen Suppository combined with Phloroglucinol during hysteroscopic examination in menopausal bleeding women
REN Wei1 LI Lili1 SHI Huixing1 ZHANG Yongcun1 YUAN Hong1 QIAN Yali1 CUI Fuchun2
1.Department of Gynecology, General Hospital of Xingtai Mining Group, Hebei Province, Xingtai 054000, China;
2.Department of Gynaecology and Obstetrics, Shijiazhuang Fourth Hospital, Hebei Province, Shijiazhuang 050000, China
Abstract：Objective To investigate the application value of Compound Naproxen Suppository combined with Phloroglucinol during hysteroscopic examination in menopausal bleeding women. Methods A total of 129 cases of menopausal bleeding patients in General Hospital of Xingtai Mining Group from December 2015 to May 2017 were selected. They were randomly divided into observation group and control group I and control group Ⅱ, 43 cases in each group. Hysteroscopy was performed in the three groups. The control group Ⅰ was given Compound Naproxen Suppository, the control group Ⅱ was given Phloroglucinol for injection, and the observation group was given Compound Naproxen Suppositories combined with Phloroglucinol for Injection. The cervical softening and dilatation, pain grading and incidence of adverse reactions were compared among the three groups. Results The cervical softening and dilatation of the observation group was better than that of the control group Ⅰ and the control group Ⅱ, and the difference was statistically significant (P < 0.05). The effect rate of softening and dilatation in the observation group [69.77% (30/43)] was higher than that in the control group Ⅰ and the control group Ⅱ [34.88% (15/43), 39.53% (17/43)], and the difference was statistically significant (P < 0.05). There was no significant difference in cervical softening and dilatation between control group Ⅰ and control group Ⅱ (P > 0.05). There was no significant difference in effecfive rate between the control group Ⅰ and the control group Ⅱ(P > 0.05). The observation group had better pain classification than the control group, and the difference between the two groups was statistically significant (P < 0.05). There was no significant difference in pain classification between the control group I and the control group Ⅱ (P > 0.05). The incidence of skin rash, urticaria, abdominal pain and fever three groups were compared, the difference was not statistically significant (P > 0.05). Conclusion Compound Naproxen Suppository combined with Phloroglucinol is helpful to improve the effective rate of cervical softening and dilatation in hysteroscopic examination of menopausal bleeding. It can effectively alleviate the pain and has certain safety.
[1] 祁燕，徐桂冉，郁金芬，等.80例围绝经期阴道出血患者的病因分布及恶性病变发生的相关因素分析[J].中国性科学，2016，25（4）：80-82.
[2] 胡彦，李岚，黄文珍，等.妈富隆联合金刚藤胶囊治疗围绝经期功能性子宫出血的效果观察[J].广西医科大学学报，2017，34（2）：262-265.
[3] Rouskova D，Mittmann K，Schumacher U，et al. Effectiveness，tolerability and acceptance of a low-dosed estradiol/dienogest formulation （Lafamme 1 mg/2 mg） for the treatment of menopausal complaints：a non-interventional observational study over 6 cycles of 28 days [J]. Gynecol Endocrinol，2015，31（7）：560-564.
[4] 吕翠芬，陈晓辉.去氧孕烯炔雌醇片、米非司酮联合归脾丸治疗围绝经期功能性子宫出血疗效观察[J].现代中西医结合杂志，2017，26（35）：3937-3939.
[5] 曹蕾，陆琴.复方醋酸棉酚治疗围绝经期功能性子宫出血患者对血清性激素水平的影响[J].中国妇幼保健，2017， 32（14）：3247-3248.
[6] 季红珍，黄红燕，应翩.米非司酮与去氧孕烯炔雌醇片对围绝经期功能性子宫出血患者子宫内膜厚度的影响及疗效观察[J].中国性科学，2014，23（8）：27-29.
[7] Paramsothy P，Harlow SD，Greendale GA，et al. Bleeding patterns during the menopausal transition in the multi-ethnic Study of Women's Health Across the Nation （SWAN）：a prospective cohort study [J]. BJOG，2014，121（12）：1564-1573.
[8] 蔡妮.间苯三酚用于宫腔镜术前宫颈软化效果观察[J].海南医学，2015，26（9）：1354-1355.
[9] Arbuckle R，Humphrey L，Abraham L，et al. Qualitative cross-cultural exploration of vaginal bleeding/spotting symptoms and impacts associated with hormone therapy in post-menopausal women to inform the development of new patient-reported measurement tools [J]. Maturitas，2014，78（3）：219-227.
[10] 张宇迪，吴霞，高丽丽，等.间苯三酚不同给药途径在宫腔镜手术前宫颈扩张效果的比较[J].中国临床医生杂志，2016，44（2）：53-54.
[11] 马俊莲.复方萘普生栓联合利多卡因在绝经后妇女宫腔镜检查中的应用[J].中国妇幼保健，2017，32（7）：1414-1415.
[12] 刘玉瑰.宫腔镜诊治围绝经期及绝经后子宫出血临床分析[J].中国临床研究，2015，28（9）：1175-1177.
[13] Marciniak A，Nawrocka-Rutkowska J，Wi■niewska B，et al. Role of office hysteroscopy in the diagnosis and treatment of uterine pathology [J]. Pol Merkur Lekarski，2015， 39（232）：251-253.
[14] Karimzadeh MA，Dehghani Firouzabadi R，Goharzad F，et al. Diagnostic value of saline contrast sonohysterography comparing with hysteroscopy for detecting endometrial abnormalities in women with abnormal uterine bleeding [J]. Iran J Reprod Med，2011，9（3）：199-202.
[15] 张守娥，张琼阁，卢保华.诊刮术联合小剂量米非司酮治疗围绝经期功能失调性子宫出血疗效观察[J].人民军医，2017，60（10）：989-991.
[16] 郝利，陈诚，高洪波.宫腔镜子宫内膜射频消融术治疗围绝经期功能失调性子宫出血的疗效评估[J].海南医学院学报，2017，23（10）：1370-1372.
[17] 沈会平，王金玲.复方萘普生栓对孕13~16周引产时宫颈软化的疗效[J].新乡医学院学报，2015，32（8）：780-781.
[18] 孙景丽，王青，高绍凤，等.间苯三酚与米索前列醇在宫腔镜术前促宫颈成熟效果比较的Meta分析[J].中国内镜杂志，2016，22（6）：72-77.
[19] 史慧星，任伟，张永存，等.复方双氯芬酸钠和间苯三酚在宫腔镜检查中镇痛效果的观察[J].中国计划生育学杂志，2016，24（7）：486-488.
[20] Damle RP，Dravid NV，Suryawanshi KH，et al. Clinicopathological Spectrum of Endometrial Changes in Peri-menopausal and Post-menopausal Abnormal Uterine Bleeding：A2 Years Study [J]. J Clin Diagn Res，2013，7（12）：2774-2776.
2018, Vol. 15 
京公网安备 11010502046598号